NantHealth, Inc., together with its subsidiaries, operates as an evidence-based personalized healthcare company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solution, an adaptive learning system, including molecular profiling solution, software, and hardware systems infrastructure that collects, indexes, analyzes, and interprets various molecular, clinical, operational, and financial data points derived from various sources to enhance decision-making. The company's products include GPS Cancer, a molecular profile that integrates whole genome sequencing of tumor and normal germline samples, whole transcriptome sequencing, and quantitative proteomics; GPS Cancer Report, a GPS cancer solution; GPS in rare diseases and chronic illnesses; and Eviti, a decision support solution. It also provides Web-based and mobile software solutions, such as Device Connectivity Suite, a device connectivity and near real-time biometric software and hardware suite; DeviceConX, a device data normalization software; HBox, an Internet of Medical Things and Internet of Things hardware hub; and VitalsConX, a tablet-optimized application. In addition, NantHealth, Inc. offers NaviNet Open, a payer-provider collaboration platform comprising plan central, eligibility and benefit, claims status inquiry, claims management, referral, authorization, document exchange, and AllPayer services; and cloud-based computing, storage, and transport infrastructure-as-a-service solutions. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was founded in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Data processing & preparation
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:NH
CUSIPN/A
Phone310-883-1300
Debt
Debt-to-Equity Ratio1.34
Current Ratio1.50
Quick Ratio1.48
Price-To-Earnings
Trailing P/E Ratio-1.22
Forward P/E Ratio-1.96
P/E GrowthN/A
Sales & Book Value
Annual Sales$86.68 million
Price / Sales1.73
Cash FlowN/A
Price / CashN/A
Book Value$1.78 per share
Price / Book0.77
Profitability
EPS (Most Recent Fiscal Year)($1.12)
Net Income$-175,210,000.00
Net Margins-124.02%
Return on Equity-49.56%
Return on Assets-20.32%
Miscellaneous
Employees494
Outstanding Shares109,470,000
Market Cap$144.50 million
